Recon: Bayer to buy US biotech Vividion for up to $2B; South Korea pledges $1.9B for COVID-19 vaccine production
ReconMichael Mezher
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy